Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate
- 1 January 2004
- book chapter
- Published by Springer Nature
- Vol. 519, 81-99
- https://doi.org/10.1007/0-306-47932-x_6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdvances in Enzyme Regulation, 2001
- Biodistribution of paclitaxel and poly( l -glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumorCancer Chemotherapy and Pharmacology, 2000
- Gamma Scintigraphy of the Biodistribution of123I-Labelled N-(2-Hydroxypropyl)methacrylamide Copolymer-Doxorubicin Conjugates in Mice with Transplanted Melanoma and Mammary CarcinomaJournal of Drug Targeting, 1996
- Experimental Peripheral Neuropathy Induced in Adult Rats by Repeated Intraperitoneal Administration of TaxolExperimental Neurology, 1995
- Polymer ConjugatesClinical Pharmacokinetics, 1994
- TOXICITY STUDIES OF PACLITAXEL (II) : One-month intermittent intravenous toxicity in ratsThe Journal of Toxicological Sciences, 1994
- TOXICITY STUDIES OF PACLITAXEL (I) : Single dose intravenous toxicity in ratsThe Journal of Toxicological Sciences, 1994
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- Poly(amino acid) Copolymers as a Potential Soluble Drug Delivery System. 1. Pinocytic Uptake and Lysosomal Degradation Measured In VitroJournal of Bioactive and Compatible Polymers, 1989